Viewing StudyNCT06414148



Ignite Creation Date: 2024-05-19 @ 5:34 PM
Last Modification Date: 2024-10-26 @ 3:29 PM
Study NCT ID: NCT06414148
Status: RECRUITING
Last Update Posted: 2024-05-16
First Post: 2024-04-29

Brief Title: MRD-Directed Consolidation With Epcor-only or Epcor-R2 Post Anti-CD19 CAR TCell Therapy for Large B-Cell Lymphoma
Sponsor: Peter MacCallum Cancer Centre Australia
Organization: Peter MacCallum Cancer Centre Australia

Conditions & Keywords Data

Conditions:
Name
RelapsedRefractory Large B-cell Lymphoma
Keywords:
Name View
Rituximab View
Minimal Residual Disease View
Large B-Cell Lymphoma View
Anti-CD19 View
CAR T View
ctDNA View
Lymphoma View
DLBCL View
HGBL View
Epcoritamab View
Lenalidomide View